WHO recommends use of Hib vaccines in all national immunization programmes
27 SEPTEMBER 2013 | GENEVA | SWITZERLAND - In an updated position paper published today in the WHO Weekly Epidemiological Record, WHO continues to recommend the inclusion of Haemophilus influenzae type b (Hib) vaccines in all national immunization programmes. Vaccination remains the only effective means of preventing Hib disease and is becoming increasingly important as Hib antibiotic resistance grows.
The use of Hib vaccines should be part of a comprehensive strategy to control pneumonia including: exclusive breastfeeding for six months; hand washing with soap; improved water supply and sanitation; reduction of household air pollution; and improved case management at community and health facility levels.
WHO recommends that any one of the following Hib immunization schedules may be followed:
- 3 primary vaccine doses without a booster vaccination
- 2 primary vaccine doses plus a booster vaccination
- 3 primary vaccine doses with a booster vaccination
Hib is a bacteria responsible for severe pneumonia, meningitis and other invasive diseases almost exclusively in children under 5 years of age. It is transmitted through the respiratory tract from infected to susceptible individuals.
WHO Position Paper on Hib vaccination - September 2013
GRADE Table 1: Level of clinical protection conferred by a complete primary series of Haemophilus influenzae type b (Hib) vaccination
GRADE Table 2: Hib vaccination schedules: three primary doses versus two primary doses plus one booster dose
GRADE Table 3: Hib vaccination schedules: three primary doses plus one booster dose versus two primary doses plus one booster dose
GRADE Table 4: Hib vaccination schedules: three primary doses plus one booster versus three primary doses only
Presentation: Summary of key points - WHO position paper on Haemophilus influenzae type b